Xilio Therapeutics XLO Cash Flow Statement (2020-2026)

NASDAQ XLO
$9.23 -0.18 (-1.91%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-31.76M-19.66M-21.42M-24.82M-20.43M-24.42M-23.73M-20.19M-17.40M-18.36M-17.80M-14.88M-14.86M-13.91M-13.91M-14.40M-2.00M-11.86M-14.13M-3.62M
Depreciation and Depletion (Quarter)
0.30M0.40M0.40M0.40M0.50M0.40M0.50M0.40M0.50M0.40M0.40M0.40M0.40M0.40M0.50M0.40M0.30M0.30M0.30M0.30M
Share-based Compensation (Quarter)
1.09M2.07M2.03M2.71M1.87M1.81M1.79M1.80M1.86M1.93M1.83M1.51M1.57M1.52M1.53M1.35M1.12M2.93M2.21M1.60M
Gains from Investment Securities (Quarter)
0.05M15.38M-21.27M-3.30M3.94M
Cash from Operations (Quarter)
-20.72M-17.16M-20.84M-16.76M-19.91M-18.22M-25.25M-16.57M-13.37M-13.43M-10.50M19.95M-13.67M-14.16M28.98M-14.48M-17.50M-2.00M-22.34M-18.76M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.04M0.05M0.05M0.05M0.06M0.06M0.03M0.09M0.02M0.02M-0.00M
Depreciation & Amortization (CF) (Quarter)
0.38M0.39M0.44M0.45M0.47M0.49M0.50M0.49M0.46M0.45M0.44M0.45M0.38M0.38M0.50M0.38M0.34M0.32M0.34M0.33M
Change in Working Capital
Change in Receivables (Quarter)
30.00M-12.50M-5.00M6.00M
Change in Account Payables (Quarter)
-3.55M-1.19M-0.82M-0.40M0.24M1.46M-1.36M-0.81M0.54M-0.44M-0.30M0.51M-0.28M1.60M-0.59M2.11M-1.80M0.43M-1.68M1.26M
Change in Accured Expenses (Quarter)
-0.30M0.84M-1.43M4.63M-3.09M1.47M-3.87M0.66M2.28M1.10M-2.50M1.25M-0.21M-0.09M-6.38M1.16M3.31M0.93M-1.54M-1.45M
Other Working Capital Changes (Quarter)
2.20M-0.46M-0.34M-0.52M-0.43M0.94M-0.41M-0.66M1.67M-1.28M1.78M34.98M-38.54M2.75M46.21M-49.29M0.50M30.46M1.21M-12.69M
Investing Activities
Capital Expenditures (Quarter)
-0.56M0.49M0.25M0.77M0.33M-1.34M0.17M0.32M0.02M0.01M0.01M0.29M0.13M0.02M0.56M0.02M
Cash from Investing Activities (Quarter)
-0.11M-0.38M-0.25M-0.77M-0.33M-0.51M-0.17M-0.32M-0.01M-0.01M-0.02M-0.40M-0.10M-0.56M-0.02M
Financing Activities
Other financing activities (Quarter)
0.01M0.24M0.02M-0.13M0.19M4.31M-4.31M0.00M0.06M0.01M0.00M35.82M0.00M0.04M
Cash from Financing Activities (Quarter)
0.30M115.83M-0.01M-0.02M-0.02M-0.02M-1.69M-0.99M-2.24M-1.63M0.95M20.04M-0.00M8.20M4.83M47.36M-0.28M35.87M35.71M4.49M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-28.53M0.00M2.02M45.02M-0.03M47.00M
Additional items
Change in Cash (Quarter)
-20.53M98.29M-21.09M-17.55M-20.26M-18.75M-27.11M-17.88M-15.61M-15.06M-9.55M39.98M-13.68M-5.96M33.79M32.48M-17.78M33.77M12.81M-14.29M
Free Cash Flow (Quarter)
-20.16M-17.65M-21.09M-17.53M-20.24M-16.88M-25.42M-16.89M-13.37M-13.43M-10.52M19.95M-13.68M-14.16M28.69M-14.61M-17.50M-2.02M-22.90M-18.78M
Net Cash Flow (Quarter)
-20.53M98.29M-21.09M-17.55M-20.26M-18.75M-27.11M-17.88M-15.61M-15.06M-9.55M40.00M-13.68M-5.96M33.79M32.48M-17.78M33.77M12.81M-14.29M